Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DIS

Disney

$134.89

-7.06 (-4.97%)

, CVS

CVS Health

$58.14

4.05 (7.49%)

17:32
08/07/19
08/07
17:32
08/07/19
17:32
On The Fly
Fly Intel: Wall Street's top stories for Wednesday »

Stocks spent the morning…

DIS

Disney

$134.89

-7.06 (-4.97%)

CVS

CVS Health

$58.14

4.05 (7.49%)

WBA

Walgreens Boots Alliance

$52.44

0.98 (1.90%)

JCP

J.C. Penney

$0.64

-0.0078 (-1.21%)

SHLD

Sears

$0.00

(0.00%)

CBM

Cambrex

$60.00

19.13 (46.81%)

WW

WW

$30.01

8.95 (42.50%)

TXMD

TherapeuticsMD

$2.29

0.42 (22.46%)

ATNX

Athenex

$15.19

-3.76 (-19.84%)

ETM

Entercom

$3.35

-1.9 (-36.19%)

AXGN

AxoGen

$12.46

-5.1 (-29.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 07

    Aug

  • 07

    Aug

  • 07

    Aug

  • 14

    Aug

  • 15

    Aug

  • 09

    Sep

  • 13

    Nov

AXGN

AxoGen

$12.67

-4.89 (-27.85%)

14:06
08/07/19
08/07
14:06
08/07/19
14:06
Recommendations
AxoGen analyst commentary at JMP Securities »

AxoGen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN

AxoGen

$17.56

0.45 (2.63%)

09:22
08/07/19
08/07
09:22
08/07/19
09:22
Recommendations
AxoGen analyst commentary at BTIG »

AxoGen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN

AxoGen

$17.56

0.45 (2.63%)

09:07
08/07/19
08/07
09:07
08/07/19
09:07
Downgrade
AxoGen rating change at William Blair »

William Blair downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN

AxoGen

$17.56

0.45 (2.63%)

07:21
08/07/19
08/07
07:21
08/07/19
07:21
Downgrade
AxoGen rating change at William Blair »

AxoGen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN

AxoGen

$17.56

0.45 (2.63%)

07:02
08/07/19
08/07
07:02
08/07/19
07:02
Recommendations
AxoGen analyst commentary at Cantor Fitzgerald »

AxoGen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN

AxoGen

$17.56

0.45 (2.63%)

16:15
08/06/19
08/06
16:15
08/06/19
16:15
Earnings
AxoGen cuts FY19 revenue view to $106M-$110M from $109M-$114M 

Consensus $111.89M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN

AxoGen

$17.60

0.49 (2.86%)

16:13
08/06/19
08/06
16:13
08/06/19
16:13
Earnings
AxoGen reports Q2 adj. EPS (10c), consensus (14c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN

AxoGen

$17.83

0.325 (1.86%)

07:14
07/26/19
07/26
07:14
07/26/19
07:14
Hot Stocks
AxoGen announces publication of 100th peer-reviewed clinical paper »

Axogen announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 14

    Aug

  • 09

    Sep

Over a month ago
AXGN

AxoGen

$20.15

0.17 (0.85%)

09:33
07/12/19
07/12
09:33
07/12/19
09:33
Initiation
AxoGen initiated at Canaccord »

AxoGen initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.